This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Caprotec Bioanalytics Gmbh. Active years: 2012-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2017
Title: Thomas Lenz: Innovator in Cell Isolation and Magnetic Particle Separation
Introduction
Thomas Lenz is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of bioanalytics, particularly in the isolation and identification of cells. With a total of 2 patents, Lenz's work is paving the way for advancements in medical and research applications.
Latest Patents
Lenz's latest patents include innovative methods for tagging, identifying, and isolating target cells. The first patent focuses on a method that involves a capture compound, which comprises a small molecule moiety capable of selectively binding to the cell surface of the target cell. This compound can also include a photoactivatable reactivity function, enhancing its utility in various applications. The second patent pertains to devices, systems, and methods for separating magnetic particles from samples. This device utilizes a magnet and an orienting pin to concentrate the magnetic field, allowing for efficient collection of magnetic beads with attached molecules.
Career Highlights
Thomas Lenz is currently associated with Caprotec Bioanalytics GmbH, where he continues to develop innovative solutions in bioanalytics. His work is instrumental in advancing techniques that improve the efficiency of cell isolation and identification.
Collaborations
Lenz collaborates with talented individuals such as Mathias Dreger and Christian Dalhoff, contributing to a dynamic research environment that fosters innovation.
Conclusion
Thomas Lenz's contributions to the field of bioanalytics through his patents and collaborative efforts highlight his role as a key innovator. His work is expected to have a lasting impact on medical research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile